Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara McGowan

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Nature Medicine|January 7, 2026
Clarification of evidence selection for the framework for the pharmacological treatment of obesity and its complications from the EASOAndreea Ciudin, Barbara McGowan
Therapeutic Advances in Chronic Disease|March 16, 2016
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesityJames Crane, Barbara McGowan
Obesity (Silver Spring, Md.)|May 26, 2026
Using the Lancet Guideline to Ration Obesity Care-Real or Imagined?Adam H Gilden, Barbara McGowan
The Journal of Endocrinology|February 3, 2005
Appetite controlKatie Wynne, Sarah Stanley, Barbara McGowan, et al.
Physiological Reviews|September 27, 2005
Hormonal regulation of food intakeSarah Stanley, Katie Wynne, Barbara McGowan, et al.
Current Obesity Reports|May 8, 2021
The Bariatric-Metabolic Physician's Role in Managing Clinically Severe ObesityClaudia Coelho, James Crane, Rachel Agius, et al.
Clinical Medicine (London, England)|February 18, 2014
The bariatric physicianPaul Grant, Milan Piya, Barbara McGowan, et al.
Internal and Emergency Medicine|April 29, 2023
Clinical evaluation of patients living with obesityLaurence J Dobbie, Claudia Coelho, James Crane, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2024
Developing an intervention to support dietary change for shift workers living with type 2 diabetes: A stakeholder consultationRachel Gibson, Nick Oliver, Barbara McGowan, et al.
Diabetes, Obesity & Metabolism|June 5, 2026
Are Women Living With Obesity More Responsive to GLP-1 Receptor Agonists? A Potential Signal From Trial-Level and Within-Trial AnalysesMatteo Monami, Simona Bertoli, Andreea Ciudin, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Nature Medicine|January 7, 2026
Clarification of evidence selection for the framework for the pharmacological treatment of obesity and its complications from the EASOAndreea Ciudin, Barbara McGowan
Therapeutic Advances in Chronic Disease|March 16, 2016
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesityJames Crane, Barbara McGowan
Obesity (Silver Spring, Md.)|May 26, 2026
Using the Lancet Guideline to Ration Obesity Care-Real or Imagined?Adam H Gilden, Barbara McGowan
The Journal of Endocrinology|February 3, 2005
Appetite controlKatie Wynne, Sarah Stanley, Barbara McGowan, et al.
Physiological Reviews|September 27, 2005
Hormonal regulation of food intakeSarah Stanley, Katie Wynne, Barbara McGowan, et al.
Current Obesity Reports|May 8, 2021
The Bariatric-Metabolic Physician's Role in Managing Clinically Severe ObesityClaudia Coelho, James Crane, Rachel Agius, et al.
Clinical Medicine (London, England)|February 18, 2014
The bariatric physicianPaul Grant, Milan Piya, Barbara McGowan, et al.
Internal and Emergency Medicine|April 29, 2023
Clinical evaluation of patients living with obesityLaurence J Dobbie, Claudia Coelho, James Crane, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2024
Developing an intervention to support dietary change for shift workers living with type 2 diabetes: A stakeholder consultationRachel Gibson, Nick Oliver, Barbara McGowan, et al.
Diabetes, Obesity & Metabolism|June 5, 2026
Are Women Living With Obesity More Responsive to GLP-1 Receptor Agonists? A Potential Signal From Trial-Level and Within-Trial AnalysesMatteo Monami, Simona Bertoli, Andreea Ciudin, et al.
Pageof 7